Dr.ย Shing Chuanย Hooi
MBBS, PhD
Professor & Cancer Biology Researcher
corporate_fareNUS Yong Loo Lin School of Medicine, Singapore
Shing Chuan Hooi
MBBS, PhD
Prof. Shing Chuan Hooi is a Singapore-based cancer biology researcher and medical educator at the Yong Loo Lin School of Medicine, National University of Singapore (NUS). His work centres on the molecular mechanisms that drive tumour growth, with a particular focus on gastrointestinal, colorectal and liver cancers.
He joined the NUS Department of Physiology in 1985 and has spent close to four decades in academic medicine and laboratory cancer research. His research interests include the regulation of C/EBPalpha in hepatocellular carcinoma, cancer cell survival under metabolic stress, and the mechanisms of cancer metastasis. Alongside his research, he is a recognised medical educator who served as Head of the Department of Physiology from 2000 to 2008 and has held senior education leadership roles within the school. His profile is most relevant for patients and referring doctors seeking a research-informed academic perspective on gastrointestinal and liver cancers within Singapore's academic cancer ecosystem.
CancerFax can coordinate medical-record review and help international patients seek a research-informed academic opinion within Singapore's cancer care ecosystem, subject to availability and case acceptance.
Why Consider Prof. Shing Chuan Hooi?
Prof. Hooi brings a research-driven academic perspective to complex gastrointestinal and liver cancers.
Areas of Academic & Research Focus
Research-driven expertise in gastrointestinal and liver cancers
Prof. Hooi's expertise is grounded in laboratory and translational cancer research rather than routine clinical treatment. The areas below reflect his published research themes.
Hepatocellular Carcinoma & Liver Cancer
Molecular biology of liver cancer and treatment-resistance mechanisms.
- arrow_rightRegulation and function of C/EBPalpha in hepatocellular carcinoma
- arrow_rightLipid metabolism in liver cancer cells
- arrow_rightACSL4 as a predictive biomarker of sorafenib sensitivity
- arrow_rightSorafenib combined with glucose restriction in HCC models
Gastrointestinal & Colorectal Cancer
Tumour growth, survival and metastasis in gastrointestinal cancers.
- arrow_rightGene mechanisms that promote tumour growth
- arrow_rightTumour-suppressor function and resistance to chemotherapy-induced apoptosis
- arrow_rightCytoskeletal dynamics and epithelial-mesenchymal transition
- arrow_rightCancer cell survival under metabolic stress
Academic & Advisory Contributions
Research-informed review and academic support
Prof. Hooi is an academic researcher and educator. He does not provide routine clinical treatment through this profile. The support below reflects academic, advisory and second-opinion functions that CancerFax can help coordinate.
Expert Academic Opinion
Second OpinionResearch-informed academic perspective on complex gastrointestinal and liver cancer cases.
Translational Research Perspective
Complex DiseaseBridging laboratory cancer biology with clinical questions in difficult cases.
Multidisciplinary Academic Input
MultidisciplinaryAcademic input within Singapore's research and teaching cancer ecosystem.
Research & Publications
Cancer biology research and peer-reviewed contributions
Prof. Hooi's research focuses on the molecular mechanisms of tumour growth, survival and metastasis, with particular emphasis on liver and gastrointestinal cancers.
A fuller list of Prof. Hooi's publications is available through his NUS and Google Scholar profiles, and can be shared on request via CancerFax.
Education & Training
Prof. Hooi trained in medicine at the National University of Singapore and completed doctoral research at Harvard University.
Clinical Experience
Prof. Hooi has spent close to four decades at the National University of Singapore in cancer research and medical education, joining the Department of Physiology in 1985.
Languages & International
Prof. Hooi works in the following languages.
CancerFax can coordinate professional medical interpreter support for international patients.
CancerFax can coordinate professional medical interpreter support for international patients when required.
How CancerFax Helps You Access Dr. Shing Chuan Hooi
CancerFax is a specialist cancer patient-navigation platform. We help international patients prepare structured medical summaries, assess treatment eligibility, and connect directly with Dr. Shing Chuan Hooi's team โ with full coordination from initial inquiry to consultation.
Medical Report Review
Free review of your pathology results, imaging, molecular profiling, and treatment history โ prepared as a structured clinical summary for Dr. Shing Chuan Hooi's team.
Treatment Eligibility Screening
CancerFax screens your case for eligibility for treatments and clinical programmes available through Dr. Shing Chuan Hooi before you travel, so you arrive with a clear pathway.
Case Submission
We coordinate direct case submission to Dr. Shing Chuan Hooi's department, including all documentation required for clinical review and appointment scheduling.
Appointment & Consultation Coordination
CancerFax manages appointment scheduling with Dr. Shing Chuan Hooi's team, confirming availability and aligning timelines with your travel plans.
Travel, Visa & Logistics Support
We prepare visa invitation letters, provide hospital-proximity accommodation guidance, and coordinate airport transfers for international patients.
Follow-Up & Continuity of Care
After your consultation or treatment, CancerFax facilitates communication between Dr. Shing Chuan Hooi's team and your home oncologist for seamless post-treatment follow-up.
Frequently Asked Questions About Prof. Shing Chuan Hooi
Prof. Hooi is a senior cancer biology researcher and medical educator at the National University of Singapore. His expertise lies in the molecular biology of gastrointestinal and liver cancers and in medical education, rather than in providing routine day-to-day cancer treatment. CancerFax can help you understand how his research-informed perspective may support your case.
His research focuses on gastrointestinal cancers, colorectal cancer, and hepatocellular carcinoma (liver cancer), including how genes drive tumour growth, treatment resistance, and cancer metastasis.
CancerFax can coordinate medical-record review and help international patients seek a research-informed academic perspective and appropriate clinical referral within Singapore's academic cancer ecosystem, subject to availability and case acceptance.
Submit your medical reports through CancerFax. Our team will review the documents, prepare the case, and coordinate the next steps with the relevant academic or clinical team in Singapore, subject to availability.
A second-opinion request can be submitted through CancerFax with the patient's pathology reports, imaging, treatment history, and relevant test results. The final consultation format and availability depend on the institution and the doctor's academic commitments.
Connect with Shing Chuan Hooi Today
Share your medical reports for a free preliminary review. Our patient coordinators will help you understand your options and arrange a direct consultation.
Medical Disclaimer: Information on this page is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making any medical decisions.